药物更新:最近的药物批准,2025年夏季版
The Nurse practitioner
|July 29, 2025
概括
美国FDA于2024年底批准了新的药物,包括多纳尼马布-阿兹巴特,纳尔梅芬注射和上腺素鼻喷雾,为初级保健提供了进步. 此外,蒂尔泽帕提德和杜皮卢马布的新适应症也获得批准.
科学领域:
- 药理学和治疗学 药理学和治疗学
- 药物的批准和监管 药物的批准和监管
- 主要护理医学 医疗保健
背景情况:
- 美国食品和药物管理局 (FDA) 在批准新药方面发挥着至关重要的作用.
- 初级保健医生需要及时更新新批准的药物和适用情况.
- 2024年底,美国食品和药物管理局 (FDA) 获得了重大批准,影响了各种治疗领域.
研究的目的:
- 总结2024年下半年与初级保健实践相关的关键FDA药物批准.
- 突出新型治疗药物和扩大现有药物的指示.
- 为医疗保健专业人员提供简洁的概述.
主要方法:
- 对FDA批准公告和新闻稿的审查.
- 在2024年7月至12月期间批准的药物的鉴定.
- 专注于具有直接或潜在初级保健应用的药物.
- 为以前批准的药物添加新的适应症.
主要成果:
- 批准用于阿尔茨海默病的多纳纳-阿兹伯特 (Kisunla).
- 批准纳尔梅芬注射 (Zurnai) 用于阿片类药物过量使用.
- 批准上腺素鼻喷雾剂 (neffy) 用于过敏反应.
- 批准用于骨质疏松症的palopegteriparatide (Yorvipath) 药物.
- 批准用于治疗精神分裂症的沙诺梅林和化 (Cobenfy).
- 批准苏洛胺乙扎德罗西尔/普罗贝尼西德 (Orlynvah) 用于尿路感染.
- 提泽帕提德 (Zepbound) 在阻塞性睡眠呼吸暂停的新适应症.
- 杜皮卢马布 (Dupixent) 在慢性阻塞性肺病中的新适应症.
结论:
- 2024年下半年推出了几种重要的新药和初级保健指示.
- 这些批准为从神经系统疾病到呼吸道疾病的各种疾病提供了新的治疗选择.
- 了解这些监管决策对于基于证据的初级保健实践至关重要.
关键词:
阿尔茨海默氏症的疾病是阿尔茨海默氏症.美国食品药品监督管理局 FDA FDA美国食品和药物管理局 (FDA) 批准急性无并发性囊炎的发生.过敏反应过敏反应过敏反应是一种过敏反应.慢性阻塞性肺病 慢性阻塞性肺病甲状腺过敏症 (hypoparathyroidism) 是一种严重的疾病.新型药物 新型药物阻塞性睡眠呼吸暂停 (SOP) 的情况.过量服用阿片类药物过量服用主要护理是一级医疗保健.精神分裂症是一种精神分裂症.更多相关视频
10:13Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
Published on: November 8, 2024
2.4K
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
9.8K
相关概念视频
Drug Regulation
1.8K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.8K
Drug Administration and Therapy Phases: Overview
753
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
753
Prescription, Nonprescription and Orphan Drugs
848
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
848
Drug Clearance: Overview
165
Drug elimination refers to drug removal from the body, either through urine or bile, by the kidneys or liver, respectively. A pharmacokinetic parameter, drug clearance, measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the drug's concentration in plasma.
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination, including...
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination, including...
165
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Drug Discovery: Overview
8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
